Olanzapine vs haloperidol: Treating delirium in a critical care setting

Intensive Care Medicine

Volumn 30, Issue 3, 2004, Pages 444-449

  Skrobik, Yoanna K ^a   Bergeron, Nicolas ^b   Dumont, Marc ^c   Gottfried, Stewart B ^d  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Corev Group ^*  (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Critical care; Delirium; Haloperidol; Olanzapine; Parkinson's disease; Therapy

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; OLANZAPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DISEASE SEVERITY; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT CONTRAINDICATION; UNIVERSITY HOSPITAL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BENZODIAZEPINES; DELIRIUM; HALOPERIDOL; HUMANS; INFUSIONS, PARENTERAL; INTENSIVE CARE UNITS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 1642415129     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-2117-0     Document Type: Article

References (38)

1. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y (2001) Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 27:1297-1304
2. Dial S, Payne J (2002) Managing delirium in the intensive care unit. Clin Pulm Med 9:260-266
3. Kishi Y, Iwasaki Y, Takezawa K, Kurosawa H, Endo S (1995) Delirium in critical care unit patients admitted through an emergency room. Gen Hosp Psychiatry 17:371-379
4. Aldemir M, Ôzen S, Kara IH, Sir A, Baç B (2001) Predisposing factors for delirium in the surgical intensive care unit. Crit Care 5:265-270
5. Ely EW, Guatam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard GR, Inouye SK (2001) The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 27:1892-1900
6. McCusker J, Cole M, Abrahamowicz M, Primeau F, Belzile E (2002) Delirium predicts 12-month mortality. Arch Intern Med 162:457-463
7. McGuire BE, Basten CJ, Ryan CJ, Gallagher J (2000) Intensive care unit syndrome: a dangerous misnomer. Arch Intern Med 160:906-909
8. Armstrong SC, Cozza KL, Watanabe KS (1997) The misdiagnosis of delirium. Psychosomatics 38:433-439
9. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y (2001) Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27:859-864
10. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). J Am Med Assoc 286:2703-2710
11. American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156:1-20
12. Breitbart W, Gibson C, Tremblay A (2002) The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer - their spouses/caregivers, and their nurses. Psychosomatics 43:183-194
13. Menza MA, Murray GB, Holmes VF, Rafuls WA (1987) Decreased extrapyramidal symptoms with intravenous haldol. J Clin Psychiatry 48:278-280
14. Wise MG, Cassem NH (1998) Behavioural disturbances in the ICU. In: Civetta JM, Taylor RW, Kirby RR (eds) Critical care. Lippincott, Philadelphia, pp 1595-1604
15. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke S, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA, Murray MJ, Peruzzi WT, Lumb PD (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30:119-141
16. King DJ, Burke M, Lucas RA (1995) Antipsychotic drug-induced dysphoria. Br J Psychiatry 167:480-482
17. Bashford G, Bradd P (1996) Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol 9:133
18. Caroff SN, Mann SC, Campbell EC (2001) Neuroleptic malignant syndrome. Adverse drug reaction bulletin, no. 209. Lippincott, Williams and Wilkins, London, pp 799-802
19. Ilchef R (1997) Neuroleptic-induced laryngeal dystonia can mimic anaphylaxis. Aust NZJ Psychiatry 31:877-879
20. Perrault LP, Denault AY, Carrier M, Cartier R, Belisle S (2000) Torsades de pointes secondary to intravenous haloperidol after coronary bypass surgery. Can J Anesth 47:251-254
21. 2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 153:948-950
22. Sipahimalani A, Masand PS (1997) Use of risperidone in delirium: case reports. Ann Clin Psychiatry 9:105-107
23. Sipahimalani A, Sime RM, Masand PS (1997) Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1:24-26
24. Sipahimalani A, Masand PS (1998) Olanzapine in the treatment of delirium. Psychosomatics 39:422-430
25. Kim K, Pae C, Chae J, Bahk W, Jun T (2001) An open pilot trial of olanzapine for delirium in the Korean population. Psychiatr Clin Neurosci 55:515-519
26. Breitbart W, Tremblay A, Gibson C (2002) An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43:175-182
27. Markowitz JS, Brown CS, Moore TR (1999) Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 33:73-85
28. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). American Psychiatric Association, Washington, DC
29. Cammarano WB, Drasner K, Katz J (1998) Pain control, sedation, and use of muscle relaxants. In: Hall JB, Schmidt GA, Wood LD, (eds) Principles of critical care medicine. McGraw Hill, New York, pp 90-97
30. McCusker J, Cole M, Bellavance F, Primeau F (1998) Delirium: reliability and validity of a new measure of severity of delirium. Int Psychogeriatr 10:421-433
31. Ramsay MA, Savege TM, Simpson BR, Goodwin R (1974) Controlled sedation with aphaxalonealphadolone. Br Med J 2:656-659
32. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980) Extrapyramidal symptom rating scale. Can J Neurol Sci 7:233
33. Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11-19
34. Skrobik Y (2002) Haloperidol should be used sparingly. Crit Care Med 30:2613-2614
35. Caroff S, Rosenberg H, Mann S, Campbell E, Sullivan K (2002) Neuroleptic malignant syndrome in the critical care unit. Crit Care Med 30:2609-2610
36. Trzepacz P (2000) Semin Clin Neuropsychiatry 5:132-148
37. Ross CA, Peyser CE, Shapiro I, Folstein MF (1991) Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 3:135-147
38. Liptzin B, Levkoff SE (1992) An empirical study of delirium subtypes. Br J Psychiatry 161:843-845